Five-Year Efficacy and Safety of Dasatinib and Imatinib by...

Five-Year Efficacy and Safety of Dasatinib and Imatinib by Baseline Comorbidity and Age in Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) from DASISION

Mauro, Michael J., Cortes, Jorge E., Hochhaus, Andreas, Shah, Neil P., Atallah, Ehab L., Abaskharoun, Mena, Sy, Oumar, Saglio, Giuseppe
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
17
Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2017.07.113
Date:
September, 2017
File:
PDF, 94 KB
english, 2017
Conversion to is in progress
Conversion to is failed